PharmDedict
-1
archive,author,author-admin,author-1,wp-theme-bridge,wp-child-theme-bridge-child,bridge-core-3.3.5.1,cookies-not-set,qode-optimizer-1.2.3,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-smooth-scroll-enabled,qode-child-theme-ver-1.0.0,qode-theme-ver-30.9.1,qode-theme-bridge,wpb-js-composer js-comp-ver-9.0.1,vc_responsive

#MedSafetyWeek 2026 is here. For Marketing Authorisation Holders, having the mandatory local pharmacovigilance contact in Bulgaria ensures continuous regulatory compliance while making adverse reaction reporting simpler and more accessible. For HCPs, patients, and other reporters, it means direct access to a knowledgeable, approachable specialist who speaks their...

CPHI may not be a specialised regulatory event, but almost every commercial decision made there has a regulatory consequence. Early regulatory involvement helps prevent compliance hurdles, additional costs and delayed market entry. We look forward to meeting you in Milan!...

Supplier qualification, ongoing oversight and quality management of subcontractors have always been integral parts of an effective pharmacovigilance (PV) system. In the context of the recent legislative development (Implementing Regulation (EU) 2025/1466) the importance of the contractual clarity with service providers was reinforced and marketing...

💶 Here’s what Marketing Authorisation Holders (MAHs) need to know about medicine prices Bulgaria is officially switching to the euro on 1 January 2026. As part of this change, the prices of all medicinal products will be aligned with the new currency, in accordance with the...